Xpert MTB/RIF Ultra 对 HIV 感染者结核性脑膜炎的诊断准确性:前瞻性队列研究
该研究在乌干达 Mbarara 连续纳入 129 例疑似脑膜炎的 HIV 感染成人,前瞻性采集脑脊液并比较 Xpert Ultra、Xpert 与培养对结核性脑膜炎的诊断表现。以统一临床病例定义判断,Xpert Ultra 敏感性为 70%,高于 Xpert 和培养的 43%;以复合参考标准判断,Xpert Ultra 敏感性为 95%,显著高于 Xpert 和培养的 45%。研究支持 WHO 将 Xpert Ultra 作为疑似结核性脑膜炎的初始诊断检测。
要点
- 对疑似结核性脑膜炎的 HIV 感染成人,Xpert Ultra 的敏感性高于 Xpert 和培养。
- 以复合参考标准判断时,Xpert Ultra 敏感性为 95%,Xpert 与培养均为 45%。
- 脑脊液检测量≥6 mL 时,结核检出率高于<6 mL 者(26% vs 7%)。
核心结论
- 在 HIV 感染成人疑似脑膜炎中,Xpert Ultra 检出的结核性脑膜炎显著多于 Xpert 或培养。
- WHO 现推荐 Xpert Ultra 作为疑似结核性脑膜炎的初始诊断检测。
研究设计与样本
- 前瞻性队列研究,在乌干达 Mbarara 连续筛查疑似脑膜炎的 HIV 感染成人。
主要发现
- 按统一病例定义(排除 Xpert Ultra 结果),23 例为很可能或确诊结核性脑膜炎。
- Xpert Ultra 敏感性 70%(95% CI 47-87;16/23),Xpert 43%(23-66;10/23),培养 43%(23-66;10/23)。
- 按复合参考标准,129 例中 22 例(17%)检出结核性脑膜炎。
- Xpert Ultra 敏感性 95%(95% CI 77-99;21/22),高于 Xpert 45%(24-68;10/22;p=0·0010)和培养 45%(24-68;10/22;p=0·0034)。
- Xpert Ultra 阳性的 21 例中,8 例仅 Xpert Ultra 阳性,其中 3 例很可能、3 例可能、2 例非结核性脑膜炎。
关键数值与推荐
- WHO 推荐 Xpert MTB/RIF 作为结核性脑膜炎初始诊断检测,其敏感性约 50-70%,培养敏感性约 60%。
- WHO 现推荐 Xpert Ultra 作为疑似结核性脑膜炎的初始诊断检测。
临床怎么用
- 对 HIV 感染成人疑似结核性脑膜炎,可优先采用 Xpert Ultra 检测脑脊液。
- 尽量采集≥6 mL 脑脊液送检,以提高结核检出率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: WHO recommends Xpert MTB/RIF as initial diagnostic testing for tuberculous meningitis. However, diagnosis remains difficult, with Xpert sensitivity of about 50-70% and culture sensitivity of about 60%. We evaluated the diagnostic performance of the new Xpert MTB/RIF Ultra (Xpert Ultra) for tuberculous meningitis. METHODS: We prospectively obtained diagnostic cerebrospinal fluid (CSF) specimens during screening for a trial on the treatment of HIV-associated cryptococcal meningitis in Mbarara, Uganda. HIV-infected adults with suspected meningitis (eg, headache, nuchal rigidity, altered mental status) were screened consecutively at Mbarara Regional Referral Hospital. We centrifuged CSF, resuspended the pellet in 2 mL of CSF, and tested 0·5 mL with mycobacteria growth indicator tube culture, 1 mL with Xpert, and cryopreserved 0·5 mL, later tested with Xpert Ultra. We assessed diagnostic performance against uniform clinical case definition or a composite reference standard of any positive CSF tuberculous test. FINDINGS: From Feb 27, 2015, to Nov 7, 2016, we prospectively evaluated 129 HIV-infected adults with suspected meningitis for tuberculosis. 23 participants were classified as probable or definite tuberculous meningitis by uniform case definition, excluding Xpert Ultra results. Xpert Ultra sensitivity was 70% (95% CI 47-87; 16 of 23 cases) for probable or definite tuberculous meningitis compared with 43% (23-66; 10/23) for Xpert and 43% (23-66; 10/23) for culture. With composite standard, we detected tuberculous meningitis in 22 (17%) of 129 participants. Xpert Ultra had 95% sensitivity (95% CI 77-99; 21 of 22 cases) for tuberculous meningitis, which was higher than either Xpert (45% [24-68]; 10/22; p=0·0010) or culture (45% [24-68]; 10/22; p=0·0034). Of 21 participants positive by Xpert Ultra, 13 were positive by culture, Xpert, or both, and eight were only positive by Xpert Ultra. Of those eight, three were categorised as probable tuberculous meningitis, three as possible tuberculous meningitis, and two as not tuberculous meningitis. Testing 6 mL or more of CSF was associated with more frequent detection of tuberculosis than with less than 6 mL (26% vs 7%; p=0·014). INTERPRETATION: Xpert Ultra detected significantly more tuberculous meningitis than did either Xpert or culture. WHO now recommends the use of Xpert Ultra as the initial diagnostic test for suspected tuberculous meningitis. FUNDING: National Institute of Neurologic Diseases and Stroke, Fogarty International Center, National Institute of Allergy and Infectious Disease, UK Medical Research Council/DfID/Wellcome Trust Global Health Trials, Doris Duke Charitable Foundation.
引用
- Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis. 2017. PMID: 28919338. doi:10.1016/S1473-3099(17)30474-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。